Related references
Note: Only part of the references are listed.Bacterial superglue enables easy development of efficient virus-like particle based vaccines
Susan Thrane et al.
JOURNAL OF NANOBIOTECHNOLOGY (2016)
Raising Expectations For Subunit Vaccine
John T. Schiller et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
A Full-Length Plasmodium falciparum Recombinant Circumsporozoite Protein Expressed by Pseudomonas fluorescens Platform as a Malaria Vaccine Candidate
Amy R. Noe et al.
PLOS ONE (2014)
IgG2 Antibodies against a Clinical Grade Plasmodium falciparum CSP Vaccine Antigen Associate with Protection against Transgenic Sporozoite Challenge in Mice
Robert Schwenk et al.
PLOS ONE (2014)
Superglue from bacteria: unbreakable bridges for protein nanotechnology
Gianluca Veggiani et al.
TRENDS IN BIOTECHNOLOGY (2014)
Why HIV Virions Have Low Numbers of Envelope Spikes: Implications for Vaccine Development
John Schiller et al.
PLOS PATHOGENS (2014)
Durable Antibody Responses Following One Dose of the Bivalent Human Papillomavirus L1 Virus-Like Particle Vaccine in the Costa Rica Vaccine Trial
Mahboobeh Safaeian et al.
CANCER PREVENTION RESEARCH (2013)
Full-Length Plasmodium falciparum Circumsporozoite Protein Administered with Long-Chain Poly(I.C) or the Toll-Like Receptor 4 Agonist Glucopyranosyl Lipid Adjuvant-Stable Emulsion Elicits Potent Antibody and CD4+ T Cell Immunity and Protection in Mice
Kathrin Kastenmueller et al.
INFECTION AND IMMUNITY (2013)
Observational Study of Vaccine Efficacy 24 Years after the Start of Hepatitis B Vaccination in Two Gambian Villages: No Need for a Booster Dose
Maimuna Mendy et al.
PLOS ONE (2013)
Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine
Robert A. Seder et al.
SCIENCE (2013)
Malaria vaccine development: persistent challenges
Ashley M. Vaughan et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
Bacterium-like particles as multi-epitope delivery platform for Plasmodium berghei circumsporozoite protein induce complete protection against malaria in mice
Krystelle Nganou-Makamdop et al.
MALARIA JOURNAL (2012)
A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants
Sara Mian-McCarthy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Roles of the Amino Terminal Region and Repeat Region of the Plasmodium berghei Circumsporozoite Protein in Parasite Infectivity
Cassandra Aldrich et al.
PLOS ONE (2012)
Toolbox for Non-Intrusive Structural and Functional Analysis of Recombinant VLP Based Vaccines: A Case Study with Hepatitis B Vaccine
Anke M. Mulder et al.
PLOS ONE (2012)
Protective Antibody and CD8+ T-Cell Responses to the Plasmodium falciparum Circumsporozoite Protein Induced by a Nanoparticle Vaccine
Stephen A. Kaba et al.
PLOS ONE (2012)
Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin
Bijan Zakeri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children
Selidji Todagbe Agnandji et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Contributions of humoral and cellular immunity to vaccine-induced protection in humans
Ian J. Amanna et al.
VIROLOGY (2011)
Full-Length Recombinant Plasmodium falciparum VAR2CSA Binds Specifically to CSPG and Induces Potent Parasite Adhesion-Blocking Antibodies
Pongsak Khunrae et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Conserved Protective Mechanisms in Radiation and Genetically Attenuated uis3(-) and uis4(-) Plasmodium Sporozoites
Kota Arun Kumar et al.
PLOS ONE (2009)
The N-terminal domain of Plasmodium falciparum circumsporozoite protein represents a target of protective immunity
Silayuv E. Bongfen et al.
VACCINE (2009)
Antigenic Variation in Plasmodium falciparum
Artur Scherf et al.
ANNUAL REVIEW OF MICROBIOLOGY (2008)
Immunity to malaria: more questions than answers
Jean Langhorne et al.
NATURE IMMUNOLOGY (2008)
Phase I Trial of an Alhydrogel Adjuvanted Hepatitis B Core Virus-Like Particle Containing Epitopes of Plasmodium falciparum Circumsporozoite Protein
Aric L. Gregson et al.
PLOS ONE (2008)
Duration of humoral immunity to common viral and vaccine antigens
Ian J. Amanna et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites
Kota Arun Kumar et al.
NATURE (2006)
An immunologically cryptic epitope of Plasmodium falciparum circumsporozoite protein facilitates liver cell recognition and induces protective antibodies that block liver cell invasion
D Rathore et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The Plasmodium circumsporozoite protein is proteolytically processed during cell invasion
A Coppi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
DNA-Salmonella enterica serovar Typhimurium primer-booster vaccination biases towards T helper 1 responses and enhances protection against Leishmania major infection in mice
UG Lange et al.
INFECTION AND IMMUNITY (2004)
Parasite-specific immunoglobulin isotypes during lethal and non-lethal murine malaria infections
EC Smith et al.
PARASITOLOGY RESEARCH (2003)
Determinants of autoantibody induction by conjugated papillomavirus virus-like particles
B Chackerian et al.
JOURNAL OF IMMUNOLOGY (2002)
A proteomic view of the Plasmodium falciparum life cycle
L Florens et al.
NATURE (2002)
Genome sequence of the human malaria parasite Plasmodium falciparum
MJ Gardner et al.
NATURE (2002)
Share Paper
